Safety and efficacy of carfilzomib (CFZ) in previously-treated systemic light-chain (AL) amyloidosis
暂无分享,去创建一个
David D. Smith | M. Liedtke | J. Kaufman | M. Rosenzweig | D. Vesole | B. Durie | V. Sanchorawala | R. Comenzo | H. Landau | E. Scott | A. Cohen | C. Gomes | C. Gasparetto | S. Lentzsch